Annual Operating Expenses
$54.12 M
-$10.94 M-16.81%
December 31, 2023
Summary
- As of February 7, 2025, MLTX annual total operating expenses is $54.12 million, with the most recent change of -$10.94 million (-16.81%) on December 31, 2023.
- MLTX annual operating expenses is now -16.81% below its all-time high of $65.06 million, reached on December 31, 2022.
Performance
MLTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$43.11 M
+$12.53 M+40.99%
September 30, 2024
Summary
- As of February 7, 2025, MLTX quarterly total operating expenses is $43.11 million, with the most recent change of +$12.53 million (+40.99%) on September 30, 2024.
- Over the past year, MLTX quarterly operating expenses has increased by +$12.53 million (+40.99%).
- MLTX quarterly operating expenses is now at all-time high.
Performance
MLTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MLTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.8% | +41.0% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MLTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.8% | at low | at high | +233.4% |
| 5 y | 5-year | -16.8% | at low | at high | +587.9% |
| alltime | all time | -16.8% | at low | at high | +587.9% |
MoonLake Immunotherapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.11 M(+41.0%) |
| Jun 2024 | - | $30.58 M(+54.3%) |
| Mar 2024 | - | $19.82 M(+31.9%) |
| Dec 2023 | $54.12 M | $15.03 M(+15.8%) |
| Sep 2023 | - | $12.98 M(-1.6%) |
| Jun 2023 | - | $13.19 M(+2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $12.93 M(-22.5%) |
| Dec 2022 | $65.06 M | $16.70 M(+13.0%) |
| Sep 2022 | - | $14.77 M(-16.3%) |
| Jun 2022 | - | $17.65 M(+10.7%) |
| Mar 2022 | - | $15.94 M(+154.4%) |
| Sep 2021 | - | $6.27 M(-80.8%) |
| Jun 2021 | - | $32.68 M |
FAQ
- What is MoonLake Immunotherapeutics annual total operating expenses?
- What is the all time high annual operating expenses for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual operating expenses year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly operating expenses year-on-year change?
What is MoonLake Immunotherapeutics annual total operating expenses?
The current annual operating expenses of MLTX is $54.12 M
What is the all time high annual operating expenses for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total operating expenses is $65.06 M
What is MoonLake Immunotherapeutics annual operating expenses year-on-year change?
Over the past year, MLTX annual total operating expenses has changed by -$10.94 M (-16.81%)
What is MoonLake Immunotherapeutics quarterly total operating expenses?
The current quarterly operating expenses of MLTX is $43.11 M
What is the all time high quarterly operating expenses for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total operating expenses is $43.11 M
What is MoonLake Immunotherapeutics quarterly operating expenses year-on-year change?
Over the past year, MLTX quarterly total operating expenses has changed by +$12.53 M (+40.99%)